Table 2.

Clinically available photosensitizers and anticipated treatment times^6,9,21.

Platform	Substance	Wavelength (nm)	Concentration (mg/kg)	Light Energy (J/cm2)	Treatment time (hours)			Target organ
					µLight222 red	µLight242 red	µLight242 blue
Porphyrin	HpD	408, 630	0.8–2.0	200–300	1157.4–1736.1	50.5–75.8	9.1–13.7	Lung, Head, Neck, Bladder
Porphyrin	ALA	410, 635	100 umol/L	3–4	34.7–138.9	1.5–6.1	0.13–13.7	Head, Neck, Bladder, Prostate
Chlorine	Temoporfin	652	0.1–0.2	20	115.7	5.1	0.9	Lip, Oral, Lung, Stomach, Pancreatic
Chlorine	Talaporfin sodium	408, 664	>2.5	100	578.7	25.3	4.3	Head, Neck
Chlorine	HPPH	408, 665	2.5–6	44.4–133.2	256.9–770.8	11.2–25.3	1.9–5.7	Lung
Padoporfin	Phthalocyanine	670–763	—	100	578.7	25.3	4.3	Lip, Pharynx, Larynx, Tongue
Porphyrin	Verteporfin	690	—	100	578.7	25.3	4.3	Eye
Texaohyrins	Lutexaphyrin	732	0.5–2	2.5–150	—	—	—	Breast